Please login to the form below
clinical services
This page shows the latest clinical services news and features for those working in and with pharma, biotech and healthcare.
International study reveals how to measure long COVID severity and impact
A set of 12 outcomes were established by researchers to set out which aspects of long COVID should be measured in all studies and clinical services. ... Researchers plan to soon publicise these recommendations to be adopted by the scientific and clinical
Latest news
-
US NIH launches mid-stage long COVID trials to evaluate at least four treatments
Rachel Levine, assistant secretary for health at the Department of Health and Human Services, said: “Clinical trials to test effective treatments and interventions are a core component of the ... Coupled with adequate supports and services, access to
-
Sartorius signs agreement to acquire Polyplus for €2.4bn
In December last year, it acquired Bio Elpida, a French biotechnology contract development and manufacturing (CDMO) company providing pre-clinical and clinical development services for cell therapy and biologics. ... In the last two years, it has also
-
LEO Pharma enters clinical trial partnership with ICON
This includes access to ICON’s laboratories, global clinical research network and decentralised clinical trial services. ... ICON’s wealth of services and leading position in clinical development will support LEO Pharma’s R&D strategy building on
-
NHS App to revolutionise digital health and care with major digital updates by 2023
2024. Further ambitions for the NHS App will see features including improved access to screening services and clinical trials, as well as easier access to child health records for parents and ... Commenting on the new features, Simon Bolton, chief
-
UK government announce £260m to boost healthcare research and manufacturing
This investment will help the NHS deliver new life-saving treatments to patients more efficiently and will help to support more diverse and inclusive clinical research. ... NHS data through digital clinical trial services and Trusted Research Environments
More from news
Approximately 2 fully matching, plus 97 partially matching documents found.
Latest Intelligence
-
The impact of pharma congresses on HCPs – virtual and in person
The benefits here may extend beyond HCPs themselves; impactful networking may in turn expand the profile of their medical institution(s), conceivably creating new opportunities such as participation in clinical trials ... Kieran Martinez is an Associate
-
Digital technology: a significant change in healthcare innovation
access to healthcare services, more efficient clinical trials, removal of barriers to clinical trial participation and improved treatment experience. ... For example, the National Health Service (NHS) in the UK is updating a mobile application that
-
Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity
The utilisation of telemedicine or at-home health services reduces or eliminates the amount of travel and associated costs often required for clinical trial participation, making clinical trials more accessible to ... Making it easier for the patient. As
-
Diversity and inclusion in clinical trials
A recent patient survey on decentralised trials conducted by ICON showed that only 10% of respondents were willing to travel more than one hour for clinical trial participation. ... Pre-register now for a copy of the report. Nuala Murphy is President,
-
The pursuit of patient diversity in clinical trials
Despite a renewed focus on patient diversity in clinical trials, the needle has barely shifted. ... Pharma is increasingly committed to ensuring trial populations are more diverse than they perhaps were in the past,” said Nuala Murphy, President, ICON
More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.
Latest appointments
-
AVENIR GLOBAL appoints global healthcare lead
We work with healthcare clients in every one of our brands, providing a wide range of services, including insights, strategic planning, public relations, medical communications, clinical trial services, creative, branding and
-
Lynn Lewis joins Envigo
For the past 15 years Lewis worked for Covance, most recently as its group vice president of business development, clinical development and commercialisation services.
-
NDA bolsters its senior team
Her new role will see her take responsibility for the group’s strategic development, growth, procedures and overall quality of all services offerings within the areas of translational science and integrated ... Meanwhile, Barbara Clendenen also joins
-
Polyphor appoints new chief medical and development officer
Dr Debra Baker joins the firm from Novartis. Polyphor has appointed Debra Baker as its new chief medical and development officer (CMDO) in a role that focuses on clinical strategy and ... Her expertise is immediately applicable to her new role as CMDO of
-
J&J’s clinical research neuroscience director joins MedAvante
Dr Michael Ropacki becomes head of R&D at the clinical data service. ... Global clinical data services company MedAvante has appointed Dr Michael Ropacki as vice president of research and development.
More from appointments
Approximately 0 fully matching, plus 26 partially matching documents found.
Latest from PMHub
-
Peadar Coyle announced as Business Development Director for Ashfield Ireland
Ashfield Ireland, the leading provider of contract services to the Irish pharmaceutical industry, announces Peadar Coyle as Business Development Director. ... We have a heritage in offering the best representatives to the Irish pharmaceutical sector and
-
Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies
FH has evolved into a deeply connected organization, delivering unified services from pre-clinical to launch and beyond. ... commercialization services and driving common standards for client experience and satisfaction across the business.
-
Costello Medical
We an independent privately-owned agency supporting the healthcare sector in the analysis, interpretation and communication of clinical and health economic data. ... Our services include medical communications, value and access and evidence development.
-
Caroline Pond joins CHASE as NHS Partnership Working Director
Caroline brings deep practical clinical experience following her role as Operations Director at Medacy, a CHASE company that delivers pharmacist-led clinical services across the UK. ... Caroline has worked as a pharmacist across general practice,
-
CHASE and Medacy will be attending Clinical Pharmacy Congress 2023
The CPC is the meeting point for clinical pharmacy professionals from across the UK. ... CHASE and Medacy will be in attendance to talk to attendees about both our Clinical Pharmacists and Pharmacist Partnership Manager services.
More from PMHub
Approximately 1 fully matching, plus 42 partially matching documents found.
Subscribe to our email news alerts
- World AIDS Day 35: Medscape’s Commitment to the Elimination of HIV through Education and Looking Towards the Future
- No “White Space” Between Live Meetings; the top 10 benefits of virtual advisory boards
- Building trust with HCPs: 6 takeaways from our industry webinar
- Eli Lilly and PRISM BioLab enter drug discovery collaboration worth over $660m
- NHS to offer stem cell transplants to patients living with rare blood disorder
- First WHO Global Clinical Trial Forum develops joint vision to improve clinical research
No results were found
PMHub
Wave Healthcare Communications
Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
